OMER

Omeros Corporation

7.25
-0.03 (-0.41%)

Omeros Corporation (OMER) Fundamentals

Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders.
SHARE INFORMATION
Market Cap$ 457,393,409
Shares Outstanding62,828,765
Float62,798,765
Percent Float99.95%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 375,000
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions256
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months1,238,675
Institutional Holdings Percent48.6%
Institutional Sold Previous 3 Months4,998,573
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent4.1
Insider Sold Previous 3 Months-
Insider Shares Owned2,603,510
TRADING INFO
52 Week High$ 7.75
52 Week Low$ 1.74
52 Week High Change$ 200.83
21 Day Moving Average$ 5.7379
21 Day Extended Moving Average$ 5.9041
50 Day Moving Average$ 5.393
50 Day Extended Moving Average$ 5.3871
200 Day Moving Average$ 3.9068
200 Day Extended Moving Average$ 4.5495
10 Day Average Volume667,418
20 Day Average Volume567,305
30 Day Average Volume591,610
50 Day Average Volume522,844
Alpha-0.005927
Beta1.0671
Standard Deviation0.214636
R20.071403
7 Day Price Change$ 1.56
7 Day Percent Change27.27%
21 Day Price Change$ 1.82
21 Day Percent Change33.21%
30 Day Price Change$ 1.62
30 Day Percent Change28.62%
Month to Date Price Change$ 1.08
Month to Date Percent Change17.42%
Quarter to Date Price Change$ 2.63
Quarter to Date Percent Change56.56%
180 Day Price Change$ 5.18
180 Day Percent Change246.67%
200 Day Price Change$ 4.54
200 Day Percent Change165.69%
Year to Date Price Change$ 5.02
Year to Date Percent Change222.12%

Omeros Corporation (OMER) Key Ratios

PROFITABILITY
EBIT Margin-13,797.9%
EBITDA Margin-13,810.5%
Pre-Tax Profit Margin-569.0%
Profit Margin Count-89.87%
Gross Margin100.0%
Profit Margin TOT-89.87%
INCOME STATEMENTS
Revenue$ 375,000
Revenue Per Share$ 0.006
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book10.50
Total Debt To Equity9.00
Int Coverage0.00
Current Ratio2.50
Leverage Ratio16.00
Quick Ratio2.40
Long Term Debt To Capital0.80
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 353,974,343
Price to Sales307.26
Price to Free Cash0.50
PE High Last 5 Years0.00
Price To Book10.50
Price To Cash Flow0.50
PE Low Last 5 Years0.00
Price to Tangible Book10.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.20
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-27.56
Return on Equity-893.25
Return on Capital-32.41

Omeros Corporation (OMER) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
Auditor-
CEOGregory A. Demopulos
Employees213
Last Audit-
CIK0001285819
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address201 Elliott Avenue West
Seattle, WA 98119
Websitehttps://www.omeros.com
Facsimile+1 206 676-5005
Telephone+1 206 676-5000
Email-


Your Recent History
NASDAQ
OMER
Omeros
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.